Uveal Melanoma
Uveal melanoma is a rare form of cancer that occurs in the uvea, the middle layer of the eye. It can spread to other parts of the body, particularly the liver, and may require specialized treatment.
Metastatic Uveal Melanoma: Tebentafusp Treatment
We are studying the effects of tebentafusp in patients with metastatic uveal melanoma that has spread to the liver. The goal is to see if it can help achieve complete responses and improve disease control.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you at least 18 years old?
- Do you have metastatic uveal melanoma (cancer that has spread from the eye)?
- Are you currently pregnant or breastfeeding?
- Are you taking any medications that suppress your immune system, like steroids or other immunosuppressants?
- Have you had any major surgery in the last 2 weeks?
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Charite Universitaetsmedizin Berlin KöR
Medical Oncology
Berlin, Germany
Hospital Universitario La Paz
Medical Oncology
Chamartín, Spain
Bellvitge University Hospital
Oncología Médica
L'Hospitalet de Llobregat, Spain
Sponsor: Grupo Espanol Multidisciplinar De Melanoma
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.